title: Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.
authors.affiliation: Immunodeficiency Clinic, University Health Network, Toronto, Canada. Electronic address: alice.tseng@uhn.ca.
authors.forename: Alice
authors.initials: A
authors.lastname: Tseng
authors.affiliation: Immunodeficiency Clinic, University Health Network, Toronto, Canada.
authors.forename: David K
authors.initials: DK
authors.lastname: Wong
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005449:Fluorenes / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000069474:Sofosbuvir / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; C586541:ledipasvir; D000069474:Sofosbuvir
keywords: DILI; Drug interaction; HIV; Hepatitis C virus; Ledipasvir